isodibut has been researched along with alrestatin in 1 studies
| Studies (isodibut) | Trials (isodibut) | Recent Studies (post-2010) (isodibut) | Studies (alrestatin) | Trials (alrestatin) | Recent Studies (post-2010) (alrestatin) |
|---|---|---|---|---|---|
| 27 | 1 | 13 | 53 | 5 | 12 |
| Protein | Taxonomy | isodibut (IC50) | alrestatin (IC50) |
|---|---|---|---|
| Aldo-keto reductase family 1 member B1 | Rattus norvegicus (Norway rat) | 1.5 | |
| Aldo-keto reductase family 1 member B1 | Homo sapiens (human) | 6.5 | |
| Aldo-keto reductase family 1 member B1 | Bos taurus (cattle) | 6.35 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hung, DT; Lee, K; Mekalanos, JJ; Pierson, E; Shakhnovich, EA | 1 |
1 other study(ies) available for isodibut and alrestatin
| Article | Year |
|---|---|
Virstatin inhibits dimerization of the transcriptional activator ToxT.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Butyrates; Dimerization; Dose-Response Relationship, Drug; Naphthalenes; Naphthalimides; Promoter Regions, Genetic; Protein Binding; Trans-Activators; Transcription Factors; Vibrio cholerae | 2007 |